Jacobs Levy Equity Management, Inc Trevena Inc Transaction History

Jacobs Levy Equity Management, Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2017 Feb 13, 2018	SELL	$1.4 - $2.6 $42,922 - $79,713	-30,659 Closed	0 $0
Q3 2017 Nov 14, 2017	SELL	$2.22 - $2.79 $5,106 - $6,417	-2,300 Reduced 6.98%	30,659 $78,000
Q2 2017 Nov 09, 2017	BUY	N/A	32,959	32,959 $76,000

Ticker TRVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 173,680,992
Market Cap $313M
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.